Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 8, 2011 - Issue 3
Submit an article Journal homepage
201
Views
14
CrossRef citations to date
0
Altmetric
Reviews

Strategies for tumor-directed delivery of siRNA

Ezharul Hoque Chowdhury Monash University Sunway Campus, Jeffrey Cheah School of Medicine and Health Sciences, Jalan Lagoon Selatan, Bandar Sunway, Selangor Darul Ehsan, Malaysia; International Medical University (IMU), School of Medicine and Health Sciences, No. 126, Jalan 19/155B, Bukit Jalil 57000, Kuala Lumpur, Malaysia +03 27317512; +03 86567229; [email protected]
Pages 389-401 | Published online: 11 Feb 2011

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Yong Tsuey Li, Ming Jang Chua, Anil Philip Kunnath & Ezharul Hoque Chowdhury. (2012) Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs. International Journal of Nanomedicine 7, pages 2473-2481.
Read now
Sundaram Ramakrishnan. (2011) Hydrogel-siRNA for cancer therapy. Cancer Biology & Therapy 11:9, pages 849-851.
Read now

Articles from other publishers (12)

Sumel Ashique, Basmah Almohaywi, Nazima Haider, Sabina Yasmin, Afzal Hussain, Neeraj Mishra & Ashish Garg. (2022) siRNA-based nanocarriers for targeted drug delivery to control breast cancer. Advances in Cancer Biology - Metastasis 4, pages 100047.
Crossref
Roja Sahu & Shakti P. Pattanayak. (2020) Strategic Developments & Future Perspective on Gene Therapy for Breast Cancer: Role of mTOR and Brk/ PTK6 as Molecular Targets. Current Gene Therapy 20:4, pages 237-258.
Crossref
Stefania Nobili, Andrea Lapucci, Ida Landini, Marcella Coronnello, Giandomenico Roviello & Enrico Mini. (2020) Role of ATP-binding cassette transporters in cancer initiation and progression. Seminars in Cancer Biology 60, pages 72-95.
Crossref
David Gomez-Zepeda, Méryam Taghi, Jean-Michel Scherrmann, Xavier Decleves & Marie-Claude Menet. (2019) ABC Transporters at the Blood–Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas. Pharmaceutics 12:1, pages 20.
Crossref
Nur Izyani Kamaruzman, Noraini Abd Aziz, Chit Laa Poh & Ezharul Hoque Chowdhury. (2019) Oncogenic Signaling in Tumorigenesis and Applications of siRNA Nanotherapeutics in Breast Cancer. Cancers 11:5, pages 632.
Crossref
Nur Kamaruzman, Snigdha Tiash, Maeirah Ashaie & Ezharul Chowdhury. (2018) siRNAs Targeting Growth Factor Receptor and Anti-Apoptotic Genes Synergistically Kill Breast Cancer Cells through Inhibition of MAPK and PI-3 Kinase Pathways. Biomedicines 6:3, pages 73.
Crossref
Tahereh Fatemian & Ezharul Chowdhury. (2018) Cytotoxicity Enhancement in Breast Cancer Cells with Carbonate Apatite-Facilitated Intracellular Delivery of Anti-Cancer Drugs. Toxics 6:1, pages 12.
Crossref
Tahereh Fatemian, Iekhsan Othman & Ezharul Hoque Chowdhury. (2014) Strategies and validation for siRNA-based therapeutics for the reversal of multi-drug resistance in cancer. Drug Discovery Today 19:1, pages 71-78.
Crossref
Ezharul Hoque Chowdhury. (2013) pH-responsive magnesium- and carbonate-substituted apatite nano-crystals for efficient and cell-targeted delivery of transgenes. Open Journal of Genetics 03:02, pages 38-44.
Crossref
Anthony Stanislaus, Athirah Bakhtiar, Diyana Salleh, Snigdha Tiash, Tahereh Fatemian, Sharif Hossain, Toshihiro Akaike & Ezharul Hoque Chowdhury. (2012) Knockdown of PLC-gamma-2 and calmodulin 1 genes sensitizes human cervical adenocarcinoma cells to doxorubicin and paclitaxel. Cancer Cell International 12:1.
Crossref
Ana Valdehita, María J. Carmena, Ana M. Bajo & Juan C. Prieto. (2012) RNA interference-directed silencing of VPAC1 receptor inhibits VIP effects on both EGFR and HER2 transactivation and VEGF secretion in human breast cancer cells. Molecular and Cellular Endocrinology 348:1, pages 241-246.
Crossref
Chan II ChangTae Yeon LeePooja DuaSoyoun KimChiang J. LiDong-ki Lee. (2011) Long Double-Stranded RNA-Mediated RNA Interference and Immunostimulation: Long Interfering Double-Stranded RNA as a Potent Anticancer Therapeutics. Nucleic Acid Therapeutics 21:3, pages 149-155.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.